---
title: "The Nasdaq Biotechnology Index rose 2.2%, reaching an intraday high since 2021"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259674133.md"
description: "The Nasdaq Biotechnology Index rose 2.2%, reaching an intraday high since 2021. Among the constituent stocks, Applied Therapeutics increased by 20.66%, Larimar Therapeutics Inc. rose by 13.16%, and Arcturus Therapeutics Holdings Inc. climbed by 10.47%. Astrazeneca ADR and Regeneron Pharma both rose by 6.6%. In contrast, uniQure NV fell by 5.14%, Design Therapeutics dropped by 5.64%, and Enanta Pharmaceuticals decreased by 13.78%"
datetime: "2025-10-01T14:12:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259674133.md)
  - [en](https://longbridge.com/en/news/259674133.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259674133.md)
generator: "portal-rs"
---

# The Nasdaq Biotechnology Index rose 2.2%, reaching an intraday high since 2021

Component stocks Applied Therapeutics rose 20.66%, Larimar Therapeutics Inc. rose 13.16%, Arcturus Therapeutics Holdings Inc. rose 10.47%, Abcellera Biologics rose 10.31%, and Design Therapeutics rose 9.93% ranking fifth. Astrazeneca ADR rose 6.6%, Regeneron Pharma rose 6.6%, and Moderna rose 6.4% performing well.

uniQure NV fell 5.14% ranking third from the bottom, Design Therapeutics fell 5.64%, and Enanta Pharmaceuticals also fell 13.78%

### Related Stocks

- [REGN.US](https://longbridge.com/en/quote/REGN.US.md)
- [ARCT.US](https://longbridge.com/en/quote/ARCT.US.md)
- [APLT.US](https://longbridge.com/en/quote/APLT.US.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [LRMR.US](https://longbridge.com/en/quote/LRMR.US.md)

## Related News & Research

- [Key facts: CHMP backs Enhertu in HER2+ adjuvant; AZN Klygefa positive](https://longbridge.com/en/news/299604745.md)
- [Arcturus to present Phase 2 ARCT-810 clinical data in OTC deficiency on Sept. 23](https://longbridge.com/en/news/299451389.md)
- [Alnylam's Sell-Off Looks Ugly -- but Wall Street Still Sees a Much Brighter Picture](https://longbridge.com/en/news/299024235.md)
- [Key facts: AstraZeneca (AZN) NICE OK Enhertu; FDA review; China plan](https://longbridge.com/en/news/299411391.md)
- [Sanofi, UCB, Opella join ERM-Secaro Clean Heat Program to cut supply chain emissions](https://longbridge.com/en/news/299179273.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**